Inverna Therapeutics

Inverna Therapeutics is developing an RNA splicing modulation platform that targets pseudo-exons to enable precise, allele-specific therapeutic interventions with minimal off-target effects. The platform's lead program focuses on Huntington's disease, leveraging a vast database of potential pseudo-exon targets to enhance treatment efficacy.

Traction 6/10

Copenhagen, Denmark · HQ

Founded 20245300+ followers

Biotechnology

Updated 6 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

2 founders

Pontus Klein

Unknown

Poul Sørensen

Serial Biotech Entrepreneur and Life Science Executive

Product

Features

Inverna Therapeutics is developing an RNA splicing modulation platform that targets pseudo-exons to enable precise, allele-specific therapeutic interventions with minimal off-target effects. The platform's lead program focuses on Huntington's disease, leveraging a vast database of potential pseudo-exon targets to enhance treatment efficacy.